Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LungStar 2 trial of pravastatin added to first-line chemotherapy for non-small cell lung cancer
ISRCTN45605573Phase 3Terminated
- Sponsor
- Imperial College London
- Start
- Jun 2006
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of pravastatin in non-small cell lung cancer (NSCLC), sponsored by Imperial College London. Primary endpoint: Overall survival. Started Jun 2006; status: terminated.
02
Drugs
pravastatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ISRCTN45605573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN45605573.